KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Equity (2016 - 2025)

Emergent BioSolutions' Return on Equity history spans 15 years, with the latest figure at 0.1% for Q4 2025.

  • For Q4 2025, Return on Equity rose 48.0% year-over-year to 0.1%; the TTM value through Dec 2025 reached 0.1%, up 48.0%, while the annual FY2025 figure was 0.1%, 44.0% up from the prior year.
  • Return on Equity reached 0.1% in Q4 2025 per EBS's latest filing, down from 0.14% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.26% in Q1 2021 to a low of 1.13% in Q4 2023.
  • Average Return on Equity over 5 years is 0.24%, with a median of 0.07% recorded in 2022.
  • Peak YoY movement for Return on Equity: tumbled -98bps in 2023, then soared 137bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.14% in 2021, then plummeted by -208bps to 0.15% in 2022, then crashed by -644bps to 1.13% in 2023, then surged by 66bps to 0.38% in 2024, then surged by 125bps to 0.1% in 2025.
  • Per Business Quant, the three most recent readings for EBS's Return on Equity are 0.1% (Q4 2025), 0.14% (Q3 2025), and 0.26% (Q2 2025).